Akums Drugs and Pharmaceuticals Q4 Results
- BSE: 544222
- NSE: AKUMS
- ISIN: INE09XN01023
- Sector: Biotechnology & Drugs
BSE
763.90
-17.55 (-2.25%)
-17.55 (-2.25%)Volume18.81 K
Updated: Fri 4 Sep, 2026 | 15:29:19
NSE
765.75-14.80 (-1.90%)
-14.80 (-1.90%)Volume3.39 L
Updated: Fri 4 Sep, 2026 | 15:52:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Akums Drugs and Pharmaceuticals Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,048.06 | 1,070.61 | -2.11% | 3,847.81 | 5.50% |
| Depreciation/ Amortization | 40.12 | 39.65 | 1.18% | 125.64 | 0.30% |
| Operating Income | 109.81 | 88.98 | 23.41% | 330.37 | 76.73% |
| Net Income | 84.61 | 66.32 | 27.59% | -4.04 | -42.68% |
| Other Operating Expenses Total | 146.65 | 144.77 | 1.30% | 59.22 | 5.77% |
| Net Income Before Taxes | 121.22 | 99.57 | 21.74% | -45.28 | 61.33% |
| Total Revenue | 1,157.87 | 1,159.59 | -0.15% | 4,178.18 | 9.69% |
| Selling/ General/ Admin Expenses Total | 199.03 | 189.38 | 5.10% | 894.75 | 8.23% |
| Diluted Normalized EPS | 5.61 | 5.14 | 9.11% | 0.83 | -39.62% |
EQUITY QUICK LINKS
FROM MARKETS
RELATED LINKS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.